Abstract
A case of convulsions in an infant requiring pyridoxine for their control has been described. On oral dosage of pyridoxine 2 mg./day, seizures have now been controlled for 21 months, with no increase in dosage being required. A continuing need for pyridoxine is demonstrated by the recent reappearance of seizures following a short lapse of pyridoxine administration. In the absence of biochemical evidence of pyridoxine deficiency, as measured by xanthurenic acid excretion following a tryptophane load, and with meager clinical evidence for the complete picture of such deficiency, the authors prefer to designate this phenomenon "pyridoxine dependency" The hypothesis has been propounded that this infant suffers a metabolic anomaly in pyridoxine metabolism resulting in convulsions in the absence of regular dietary pyridoxine supplements.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
